CClinicalTrials.gg
CompletedNCT02085499Updated May 16, 2024

Flow-synchronized Nasal IMV in Preterm Infants

An interventional study of non-synchronized NIMV and Synchronized NIMV in Premature Infant Disease and Respiratory Insufficiency, sponsored by University of Miami. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2024-05-16.

Sponsored by University of Miami · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
11
Allocation
Randomized
Sex
All
01

Study summary

The use of non-invasive methods of respiratory support to reduce complications of prolonged invasive mechanical ventilation in preterm infants has increased.

The most common mode is nasal intermittent mandatory ventilation (NIMV). In NIMV, the interval between mechanical breaths is fixed and is determined by the frequency dialed by the clinician. Asynchrony between the infant's spontaneous breathing may exist since mechanical breaths delivered at fixed intervals can occur at different times over the inspiratory or expiratory phases of the infant's spontaneous breathing. Synchronized-NIMV is a mode similar to NIMV where the ventilator cycle is delivered in synchrony with the infant's spontaneous inspiration. This has been achieved by using techniques to detect the infant's spontaneous inspiration.

The advantages or disadvantages of synchronized compared to non-synchronized NIMV remain to be determined.

This study seeks to evaluate the effect of synchronized NIMV versus non-synchronized NIMV on ventilation and gas exchange in premature infants who require supplemental oxygen.

The hypothesis is that the use of flow synchronized nasal intermittent mandatory ventilation (S-NIMV) in comparison to non-synchronized NIMV will improve ventilation and gas exchange and reduce breathing effort.

The objective of the study is to compare the effect of flow synchronized-NIMV to non-synchronized-NIMV on tidal volume (VT), minute ventilation (VE), gas exchange, breathing effort, apnea and chest wall distortion in preterm neonates with lung disease.

02

Conditions studied

  • Premature Infant Disease
  • Respiratory Insufficiency

Keywords

  • nasal ventilation
  • premature infants
  • synchronized ventilation
  • non-invasive respiratory support
03

In context

Respiratory Insufficiency

1,650 studies on the registry are indexed under Respiratory Insufficiency; 296 are open to participants now.

This study's enrollment of 11 is below the median of 55 across 1,043 interventional studies indexed under Respiratory Insufficiency.

Browse Respiratory Insufficiency studies →

Lead sponsor

University of Miami is the lead sponsor of 820 studies on the registry; 161 are open to participants now.

Of its 111 completed or terminated interventional studies of FDA-regulated products, 93 (84%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Preterm infants of 30 or less weeks of gestational age
  • Receiving NIMV
  • Requiring Fi02 > 0.21 to keep Sp02 > 90%
  • Parental written informed consent

Exclusion criteria

Exclusion Criteria:

  • Major congenital anomalies
  • Proven sepsis within 72 hours of the study
  • Hypotension requiring pressors within 72 hours of the study
  • Pneumothorax or pneumomediastinum within 72 hours of the study
  • Current suspected necrotizing enterocolitis, spontaneous perforation or severe abdominal distention
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
11 participants (actual)

Study arms

  • Other
    NIMV followed by S-NIMV

    During the study infants assigned to this arm will undergo a 2-hour period of non-synchronized NIMV followed by a 2-hour period of Synchronized-NIMV.

    Other: non-synchronized NIMV · Other: Synchronized NIMV

  • Other
    S-NIMV followed by NIMV

    During the study infants assigned to this arm will undergo a 2-hour period of synchronized NIMV followed by a 2-hour period of non-synchronized NIMV.

    Other: non-synchronized NIMV · Other: Synchronized NIMV

Interventions

  • Othernon-synchronized NIMV

    During the study each infant will undergo a 2-hour period of NIMV at a frequency of 30 cycles per minute. NIMV will be provided by a time cycled, pressure limited neonatal ventilator (Puritan Bennett 840, Covidien, Boulder, CO).

  • OtherSynchronized NIMV

    During the study each infant will undergo a 2-hour period of S-NIMV at a frequency of 30 cycles per minute. S-NIMV will be provided by a time cycled, pressure limited neonatal ventilator, with leak compensation capacity and nasal flow triggered ventilation (Puritan Bennett 840, Covidien, Boulder, CO). Synchronization will be achieved by the leak compensation software and the internal sensor of the ventilator.

06

What researchers measure

Primary outcomes

  1. Minute Ventilation

    Measurements of minute ventilation (VE in ml-units/min/Kg) by respiratory inductance plethysmography during flow synchronized-NIMV will be compared to measurements during non-synchronized-NIMV

    Time frame: 4 hours

  2. Ttidal volume (VT)

    Measurements of tidal volume (VT in ml-units/Kg) by respiratory inductance plethysmography during flow synchronized-NIMV will be compared to measurements during non-synchronized-NIMV

    Time frame: 4 hours

Secondary outcomes

  1. Arterial oxygen saturation

    Measurements of arterial oxygen saturation (%) by pulse oximetry obtained during flow synchronized-NIMV will be compared to measurements obtained during non-synchronized-NIMV

    Time frame: 4 hours

  2. fraction of inspired oxygen

    Required fraction of inspired oxygen during flow synchronized-NIMV will be compared to measurements obtained during non-synchronized-NIMV

    Time frame: 4 hours

  3. transcutaneous carbon dioxide tension

    Measurements of transcutaneous carbon dioxide tension (mmHg) obtained during flow synchronized-NIMV will be compared to measurements obtained during non-synchronized-NIMV

    Time frame: 4 hours

Other outcomes

  1. Inspiratory breathing effort

    Measurements of inspiratory breathing effort obtained by esophageal manometry (cmH2O) during flow synchronized-NIMV will be compared to measurements obtained during non-synchronized-NIMV

    Time frame: 4 hours

  2. Chest wall distortion by Tcd/Vt ratio

    Measurements of inspiratory chest wall distortion (Tcd/Vt ratio) obtained during flow synchronized-NIMV will be compared to measurements obtained during non-synchronized-NIMV

    Time frame: 4 hours

  3. Chest wall distortion by phase lag

    Measurements of inspiratory chest wall distortion (phase lag in degrees) obtained during flow synchronized-NIMV will be compared to measurements obtained during non-synchronized-NIMV

    Time frame: 4 hours

  4. apnea frequency

    Measurements of apneic respiratory pauses (#/hour) obtained during flow synchronized-NIMV will be compared to measurements obtained during non-synchronized-NIMV

    Time frame: 4 hours

07

Study locations

1 site
  • Holtz Childrens Hospital-Jackson Health System-University of Miami
    Miami, Florida 33136, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 16, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02085499
Lead sponsor
University of Miami
Responsible party
Nelson Claure (Research Associate Professor, University of Miami) — Principal investigator
First posted
Mar 13, 2014
Start date
Mar 2014
Primary completion
Jun 1, 2018
Completion
Jun 1, 2018
Last update
May 16, 2024

Study contacts

Nelson Claure, MSc, PhD
principal investigator · University of Miami
Eduardo Bancalari, MD
principal investigator · University of Miami

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion